Europe and Middle East & Africa Meningitis Diagnostic Testing Market: Introduction
According to the report, the meningitis diagnostic testing market in EMEA was valued at US$ 55.95 Mn in 2020 and is projected to expand at a CAGR of 3.7% from 2021 to 2031. Awareness about meningitis, its symptoms, and medications is most important for patients. Several meningitis disease awareness programs have been initiated to increase awareness among people.
In Africa, the Meningitis Vaccine Project (MVP) was an international partnership that began in 2010 and focused on the development, testing, licensure, and widespread introduction of a conjugate vaccine with the promise of protecting millions of lives from group A meningococcal meningitis. Increase in awareness about new meningitis diagnosis test, healthcare techniques, and disease indication is projected to boost the growth of the market in EMEA during the forecast period. Moreover, surge in global healthcare expenditure led by rise in disposable income is anticipated to drive the meningitis diagnostic testing in the near future. Rise in healthcare expenditure led by surge in awareness about different healthcare programs and availability of cost-effective diagnostic methods are expected to fuel the growth of the meningitis diagnostic testing market in EMEA during the forecast period.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84238
Lateral Flow Assay Segment to Lead Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market
In terms of product type, the meningitis diagnostic testing market in EMEA has been classified into latex agglutination tests, lateral flow assay, PCR assay, ELISA tests, culture test, and others. The lateral flow assay segment is projected to account for major share of the meningitis diagnostic testing market in EMEA during the forecast period. The growth of the segment can be attributed to low cost of lateral flow assays (US$ 2 per test in low-income countries and US$ 5 per test in high-income countries), rapid & reliable results in near-patient settings, and lack of requirement for any lab infrastructure or cold chain transport. The test is utilized to detect bacterial meningitis. Rise in prevalence of bacterial meningitis is expected to propel the segment during the forecast period.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84238
Preference for Syndromic Full Multiplex Panel
Based on panel type, the meningitis diagnostic testing market in EMEA has been bifurcated into syndromic full multiplex panel and low plex panel. The syndromic full multiplex panel segment held major market share in 2020. Increase in use of syndromic full multiplex panel in the diagnosis of different types of meningitis is likely to augment the segment during the forecast period. Instant identification of different types of meningitis in diagnostic labs using syndromic full multiplex panels has allowed higher response time and shorter waiting time.
Easy availability of syndromic full multiplex panels and rise in use of this type of panel in meningitis diagnosis are projected to propel the syndromic full multiplex panel segment over the next few years.
Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84238
Hospitals to be Major End-user
In terms of end-user, the meningitis diagnostic testing market in EMEA has been divided into hospitals, diagnostic laboratories, and others. Meningitis is a fatal disease that requires immediate care. Therefore, increase in number of hospital visits and rise in prevalence of meningitis are projected to boost the growth of the hospitals segment during the forecast period. The diagnostic centers segment held the second largest share of the market in 2020. Diagnostic centers are specially meant only for disease detection. These are well equipped with sophisticated instruments, hence people in developing and under-developed countries prefer diagnostics centers.
Europe to Lead Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market
Europe dominated the meningitis diagnostic testing market in EMEA in 2020, accounting for 60.7% market share. The availability of rapid diagnostic tests, routine vaccination programs to prevent meningitis, and increase in patient awareness are projected to drive the market in Europe during the forecast period.
Middle East & Africa is a rapidly expanding market for meningitis diagnostic testing. The market in the region is anticipated to expand at a high CAGR from 2021 to 2031 due to rise in demand for meningitis diagnostic testing.
Ask References @ https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84238
Competition Landscape
The meningitis diagnostic testing market in EMEA is fragmented due to the presence of a large number of leading players. Key players operating in the market include Thermo Fisher Scientific, Inc., Abbott Laboratories, BioFire Diagnostics, Bio-Rad Laboratories, Inc., ELITechGroup, Fast Track Diagnostics Ltd. (Siemens Healthineers), IMMY, Nanosphere (Luminex Corporation), Seegene, Inc. and Qnostics.
Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market: Segmentation
- Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market, by Product Type
- Latex Agglutination Tests
- Lateral Flow Assay
- PCR Assay
- ELISA Tests
- Culture Test
- Others
- Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market, by Panel Type
- Syndromic Full Multiplex Panel
- Low Plex Panel
- Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market, by End-user
- Hospitals
- Diagnostic Centers
- Others
Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=84238
- Europe and Middle East & Africa Market Meningitis Diagnostic Testing Market, by Region
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- Denmark
- Finland
- Austria
- Switzerland
- Benelux
- Norway
- Poland
- Rest of Europe
- GCC Countries
- South Africa
- Rest of Middle East & Africa
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact Us:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]